Avalyn Pharma Inc (AVLN)

Over the last 90 days, Avalyn Pharma Inc. has seen significant insider buying activity, with a total buy value of $24,999,984 and no reported sells. Three net buying insiders were recorded. Notable transactions include substantial purchases by SR ONE CAPITAL MANAGEMENT, LLC and Novo Holdings A/S, alongside a purchase by insider Jill Carroll.
Stock chart
Ticker: AVLN Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Novo Holdings A/S
1 purchase — total 9,999,990 USD
Buy 1 May 2026
Value US$530,390.47 | Price 121.37 | Shares 55,432
Buy 1 May 2026
Value US$3,200,751.58 | Price 143.51 | Shares 19,977
Buy 1 May 2026
Value US$4,999,986.00 | Price 18.00 | Shares 277,777
Buy 1 May 2026
Value US$5,000,004.00 | Price 18.00 | Shares 277,778
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-05 2026-05-01 B Purchase Large shareholder
55,432 +22.4%
121.37
US$530,390
55,432 +22.4% 121.37 US$530,390
2026-05-01 2026-05-01 B Purchase Non-Executive Director
19,977 -9.8%
143.51
US$3,200,752
19,977 -9.8% 143.51 US$3,200,752
2026-05-01 2026-05-01 B Purchase Large shareholder
61,796 +36.5%
378.27
US$1,613,353
61,796 +36.5% 378.27 US$1,613,353
2026-05-01 2026-05-01 B Purchase Large shareholder
277,778 +14.6%
18.00
US$5,000,004
277,778 +14.6% 18.00 US$5,000,004